0000899243-21-034732.txt : 20210901
0000899243-21-034732.hdr.sgml : 20210901
20210901163421
ACCESSION NUMBER: 0000899243-21-034732
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210830
FILED AS OF DATE: 20210901
DATE AS OF CHANGE: 20210901
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Chopas James George
CENTRAL INDEX KEY: 0001836430
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38276
FILM NUMBER: 211230429
MAIL ADDRESS:
STREET 1: 950 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Apellis Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001492422
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 271537290
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 FIFTH AVENUE
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 617-977-5700
MAIL ADDRESS:
STREET 1: 100 FIFTH AVENUE
CITY: WALTHAM
STATE: MA
ZIP: 02451
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-08-30
0
0001492422
Apellis Pharmaceuticals, Inc.
APLS
0001836430
Chopas James George
C/O APELLIS PHARMACEUTICALS, INC.
100 FIFTH AVENUE
WALTHAM
MA
02451
0
1
0
0
See Remarks
Common Stock
2021-08-30
4
A
0
7600
0.00
A
7600
D
Stock Option (right to buy)
65.41
2021-08-30
4
A
0
21750
0.00
A
2031-08-29
Common Stock
21750
21750
D
The shares are issuable upon vesting of restricted stock units that each represent a contingent right to receive one share of APLS common stock. The restricted stock units vest as to 25% of the shares underlying the award on the first anniversary of the grant date and as to an additional 25% of the shares underlying the award annually until the fourth anniversary of the grant date, subject to continued service.
This option was granted on August 30, 2021 and vests as to 25% of the shares underlying the option on the first anniversary of the grant date and thereafter as to 1/48th of the shares underlying the option monthly until the fourth anniversary of the grant date, subject to continued service.
VP, Corporate Controller / Chief Accounting Officer
/s/ David Watson, attorney-in-fact for James Chopas
2021-09-01